Abarelix acetate structure
|
Common Name | Abarelix acetate | ||
---|---|---|---|---|
CAS Number | 785804-17-3 | Molecular Weight | 1476.115 | |
Density | N/A | Boiling Point | N/A | |
Molecular Formula | C74H99ClN14O16 | Melting Point | N/A | |
MSDS | N/A | Flash Point | N/A |
Use of Abarelix acetateAbarelix acetate is a synthetic third generation gonadotropin-releasing hormone receptor (GnRHR) antagonist. It increases histamine release from rat peritoneal mast cells in vitro and from a human skin model ex vivo. In vivo, abarelix decreases plasma luteinizing hormone (LH) levels six hours post-treatment in castrated rats, with levels returning to baseline within 24 hours.3 Abarelix (2 mg/kg) also transiently decreases plasma testosterone levels in intact rats, with levels returning to baseline within seven days post-treatment. Formulations containing abarelix have previously been used in the treatment of advanced prostate cancer. |
Name | Abarelix (acetate) |
---|---|
Synonym | More Synonyms |
Molecular Formula | C74H99ClN14O16 |
---|---|
Molecular Weight | 1476.115 |
Exact Mass | 1474.705200 |
Abarelix (acetate) |
D-Alaninamide, N-acetyl-3-(2-naphthalenyl)-D-alanyl-4-chloro-D-phenylalanyl-3-(3-pyridinyl)-D-alanyl-L-seryl-N-methyl-L-tyrosyl-D-asparaginyl-L-leucyl-N6-(1-methylethyl)-L-lysyl-L-prolyl-, acetate ( 1:1) |
MFCD17011970 |
N-Acetyl-3-(2-naphthyl)-D-alanyl-4-chloro-D-phenylalanyl-3-(3-pyridinyl)-D-alanyl-L-seryl-N-methyl-L-tyrosyl-D-asparaginyl-L-leucyl-N6-isopropyl-L-lysyl-L-prolyl-D-alaninamide acetate (1:1) |